Active ingredientCarbetocinCat. No. P-C036-001CAS 37025-55-1Family · Pharmaceutical analytical standards
Carbetocin
A long-acting analogue of oxytocin, first described in 1974 and approved in 1997 in Canada and the United Kingdom to prevent bleeding after childbirth, especially after caesarean section. This family brings together the active ingredient and other impurities.
Did you know?A heat-stable formulation stays effective for at least three years at 30 °C without refrigeration: a WHO study of almost 30,000 women in 10 countries, published in 2018, found it as safe and effective as oxytocin.
Go to the active ingredient →Active ingredientCarbetocinCat. No. P-C036-001CAS 37025-55-1
Active ingredientCarbetocin AcetateCat. No. P-C036-002CAS 1631754-28-3![[Asp5] Carbetocin TFA Salt](https://img.vitasanlabs.com/vsl-struct/P-C036-003.svg?v=41e934f030)
Impurity[Asp5] Carbetocin TFA SaltCat. No. P-C036-003![[Glu4] Carbetocin TFA Salt](https://img.vitasanlabs.com/vsl-struct/P-C036-006.svg?v=41e934f030)
Impurity[Glu4] Carbetocin TFA SaltCat. No. P-C036-006
ImpurityCarbetocin Impurity 1Cat. No. P-C036-008CAS 1352167-71-5
ImpurityCarbetocin Impurity 2Cat. No. P-C036-009CAS 260057-53-2
ImpurityCarbetocin Impurity 3Cat. No. P-C036-010
ImpurityCarbetocin Impurity 4Cat. No. P-C036-015
ImpurityCarbetocin S-Oxide IICat. No. P-C036-021
ImpurityD-Asn5-Carbetocin TFA SaltCat. No. P-C036-022
Impuritydes-Gln3-CarbetocinCat. No. P-C036-023CAS 260057-56-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.